StockTimes - Categories

Category: Pharmaceuticals

Pharmaceuticals • 28.04.25

Merck Acquires US Cancer Specialist Springworks in $3 Billion Deal

Merck acquires Springworks Therapeutics for $3 billion, boosting its oncology pipeline with innovative cancer treatments. A game-changer for rare disease therapies.

StockTimes Content Team

Previous 1 Next

Cryptocurrency • 23.04.25

SEC Intensifies Crypto Crackdown: $198M Fraud Case While Dropping Charges Against Richard Heart

StockTimes Content Team

Economy • 11.04.25

UK Economy Surges Beyond Expectations with 0.5% Growth in February

StockTimes Content Team

Politics • 13.03.25

German Bundestag: Greens Reject Black-Red Coalition's Financial Package

StockTimes Content Team

Geopolitics • 13.04.25

Who Is Tom Dans? The Trump Ally Pushing for Greenland’s Annexation by the U.S.

StockTimes Content Team

Cryptocurrency • 29.03.25

Why the Crypto Market Is Plunging: Bitcoin Drops to $82K Amid Macroeconomic Fears

StockTimes Content Team

Finance • 08.03.25

Volatility Shakes Up the Market with XRP ETF Filings

StockTimes Content Team

Finance • 23.04.25

US Stock Market Downturn: A Buying Opportunity or a Warning Sign?

StockTimes Content Team

Economy • 11.04.25

UK Economy Surges Beyond Expectations with 0.5% Growth in February

StockTimes Content Team

Cryptocurrency • 29.03.25

Why the Crypto Market Is Plunging: Bitcoin Drops to $82K Amid Macroeconomic Fears

StockTimes Content Team

Politics • 27.04.25

BSW Power Struggle: Sahra Wagenknecht Fails to Oust Katja Wolf as Thuringian Leader

StockTimes Content Team

Finance • 14.04.25

JPMorgan Expands Blockchain Payments with GBP Integration on Kinexys

StockTimes Content Team

Cryptocurrency • 04.04.25

PayPal Expands Crypto Services with Solana and Chainlink: A Strategic Move for Mass Adoption

StockTimes Content Team

Category: Pharmaceuticals

StockTimes Content Team

Categories

Tags